Cargando…

FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis

Nonalcoholic fatty liver (NAFLD) may progress to nonalcoholic steatohepatitis (NASH) and ultimately to cirrhosis and hepatocellular carcinoma (HCC). Prognostic markers for these conditions are poorly defined. The aim of this study was to identify predictive gene markers for the transition from NAFL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coilly, Audrey, Desterke, Christophe, Guettier, Catherine, Samuel, Didier, Chiappini, Franck
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930227/ https://www.ncbi.nlm.nih.gov/pubmed/31874999 http://dx.doi.org/10.1038/s41598-019-56235-y

Ejemplares similares

Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients
por: Chiappini, Franck, et al.
Publicado: (2017)

Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models
por: Chiappini, Franck, et al.
Publicado: (2016)

Fatty acid-binding protein-4 (FABP4) and matrix metalloproteinase-9 (MMP9) as predictive values for nonalcoholic steatohepatitis (NASH)
por: Wagner, Jonas, et al.
Publicado: (2023)

Lipid Related Genes Altered in NASH Connect Inflammation in Liver Pathogenesis Progression to HCC: A Canonical Pathway
por: Desterke, Christophe, et al.
Publicado: (2019)

Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC)
por: Tang, Zhiyuan, et al.
Publicado: (2016)

Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma
por: Liu, Zhen, et al.
Publicado: (2010)

Determination of FABP4, RBP4 and the MMP-9/NGAL complex in the serum of women with breast cancer
por: Tsakogiannis, Dimitris, et al.
Publicado: (2021)

Fatty Acid Binding Proteins FABP9 and FABP10 Participate in Antibacterial Responses in Chinese Mitten Crab, Eriocheir sinensis
por: Cheng, Lin, et al.
Publicado: (2013)

Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease
por: Mukai, Takako, et al.
Publicado: (2017)

Circulating fatty acid-binding protein 1 (FABP1) and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
por: Lu, Yung-Chuan, et al.
Publicado: (2020)

Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation
por: Samuel, Didier, et al.
Publicado: (2018)

Paediatric acute liver failure: Confirm the outbreak, find the cause and explore the mechanisms
por: Coilly, Audrey, et al.
Publicado: (2022)

Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer
por: Reis, Sabrina Thalita, et al.
Publicado: (2012)

Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature
por: Peng, Chengyuan, et al.
Publicado: (2016)

Lack of MMP-9 expression is a marker for poor prognosis in Dukes’ B colorectal cancer
por: Koskensalo, Selja, et al.
Publicado: (2012)

FABP4 is an independent risk factor for lymph node metastasis and poor prognosis in patients with cervical cancer
por: Li, Guoqing, et al.
Publicado: (2021)

Overexpression of MMP21 and MMP28 is associated with gastric cancer progression and poor prognosis
por: Zhang, Jizhen, et al.
Publicado: (2018)

High expression level of MMP9 is associated with poor prognosis in patients with clear cell renal carcinoma
por: Niu, Haitao, et al.
Publicado: (2018)

Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma
por: Liang, Yu, et al.
Publicado: (2006)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
por: Zhong, Cheng‐Qian, et al.
Publicado: (2018)

Advanced epithelioid hemangioendothelioma of the liver: could lenvatinib offer a bridge treatment to liver transplantation?
por: Kounis, Ilias, et al.
Publicado: (2022)

Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma
por: Kunz, Pierre, et al.
Publicado: (2016)

Gamma-Smooth Muscle Actin Expression Is Associated with Epithelial-Mesenchymal Transition and Stem-Like Properties in Hepatocellular Carcinoma
por: Benzoubir, Nassima, et al.
Publicado: (2015)

Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma
por: Li, Jiangfen, et al.
Publicado: (2019)

Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer
por: Yang, Haoran, et al.
Publicado: (2021)

FABP1 and FABP2 as markers of diabetic nephropathy
por: Tsai, I-Ting, et al.
Publicado: (2020)

I-FABP is decreased in COVID-19 patients, independently of the prognosis
por: Guedj, Kevin, et al.
Publicado: (2021)

The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis
por: Li, Hai, et al.
Publicado: (2017)

Scinderin Is a Novel Oncogene for Its Correlates with Poor Prognosis, Immune Infiltrates and Matrix Metalloproteinase-2/9 (MMP2/9) in Glioma
por: Wang, Yiwei, et al.
Publicado: (2022)

Interferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug Resistance
por: Roche, Bruno, et al.
Publicado: (2015)

NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma
por: Sun, Yu, et al.
Publicado: (2017)

High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China
por: Han, Ju, et al.
Publicado: (2012)

MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma
por: Shen, Zhenghai, et al.
Publicado: (2017)

High expression of MMP19 is associated with poor prognosis in patients with colorectal cancer
por: Chen, Zaiping, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
por: Chrysavgis, Lampros, et al.
Publicado: (2020)

High expression of FABP4 and FABP6 in patients with colorectal cancer
por: Zhang, Yaqin, et al.
Publicado: (2019)

FABP1 controls hepatic transport and biotransformation of Δ(9)-THC
por: Elmes, Matthew W., et al.
Publicado: (2019)

High LINC01605 expression predicts poor prognosis and promotes tumor progression via up-regulation of MMP9 in bladder cancer
por: Qin, Zhiqiang, et al.
Publicado: (2018)

Correction: High LINC01605 expression predicts poor prognosis and promotes tumor progression via upregulation of MMP9 in bladder cancer
Publicado: (2020)

Retraction: High LINC01605 expression predicts poor prognosis and promotes tumor progression via upregulation of MMP9 in bladder cancer
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sni2tmd6ppiiv21tec8k43r1je